Physician
Michigan Cancer Specialists, PLC
Michigan Cancer Specialists, PLC was paid $601K by Medicaid between Jan 2018 and Jul 2020, across 32 billing codes. Its largest line is 99232, hospital visit by a doctor, follow-up day — 23% of everything it billed.
33Billing provider infoMICHIGAN CANCER SPECIALISTS, PLC
ROSEVILLE, MI 48066
ROSEVILLE, MI 48066
33aNPI1023048345assigned 07/03/2006
33bProvider typeMedical Oncology Physician
28Total paid$601K
24GClaims22,510
24DCodes billed32
24AFirst – last monthJan 2018 – Jul 2020
Compared with peers
Next to other Medical Oncology Physician providers in Michigan
Rank by total paid#1 of 6
Median peer was paid$62K
This provider vs. median9.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,350 | $254K | |
| 2019 | 8,856 | $250K | |
| 2020 | 4,304 | $96K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 23% | 3,585 | 943 | $138K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 15% | 1,188 | 1,005 | $91K |
| 99223 | Prolong inpt eval add15 m | 14% | 798 | 737 | $85K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 1,234 | 1,175 | $68K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 11% | 1,534 | 738 | $66K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.0% | 435 | 238 | $24K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.5% | 733 | 343 | $21K |
| 96367 | 3.4% | 1,396 | 666 | $20K | |
| 99205 | Prolong outpt/office vis | 2.4% | 132 | 129 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 2,130 | 1,455 | $13K |
| 96417 | 1.7% | 402 | 232 | $10K | |
| 80053 | Comprehensive metabolic panel | 1.7% | 1,124 | 827 | $10K |
20 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 1,402 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 589 | $4K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 107 | $4K |
| 96415 | <1% | 225 | $3K | |
| 96523 | <1% | 221 | $3K | |
| 96411 | <1% | 113 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,807 | $2K |
| 96416 | <1% | 45 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 63 | $2K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 906 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,458 | $1K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 76 | $1K |
| J9263 | Injection, oxaliplatin, 0.5 mg | <1% | 30 | $941.34 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 12 | $764.70 |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 50 | $470.28 |
| 85610 | <1% | 142 | $457.05 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 104 | $150.18 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 328 | $138.70 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 114 | $100.68 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 27 | $25.64 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAGNONE, EUGENE (OWNER)